Rapport Therapeutics, Inc. · NASDAQ:RAPP

Yeleswaram Krishnaswamy sold 50,160 Rapport Therapeutics, Inc. shares (Form 4)

Traded Aug 24 to Aug 25, 2026 · Filed Aug 26, 2026

From Aug 24 to Aug 25, 2026, Yeleswaram Krishnaswamy (Chief Development Officer) sold 50,160 Rapport Therapeutics, Inc. shares at an average US$50.47 for US$2.53M under a trading plan, leaving 195,862 shares. Filed Aug 26, 2026 (Form 4).

Sold
50,160 shares
Price
US$50.47 average (US$50.00 to US$51.06)
Value
US$2.53M
Holding after
195,862 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 24, 2026Common StockSale13,160US$50.00232,862Direct
Aug 25, 2026Common StockSale20,799US$50.31212,063Direct
Aug 25, 2026Common StockSale16,201US$51.06195,862Direct

Source

View original at SEC

Related